Published in BMC Health Serv Res on December 13, 2012
Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel) (2016) 0.86
Physicians' perceived barriers to management of sexually transmitted infections in Vietnam. BMC Public Health (2014) 0.78
Engaging migrants and other stakeholders to improve communication in cross-cultural consultation in primary care: a theoretically informed participatory study. BMJ Open (2016) 0.76
Critical attitudes and beliefs towards guidelines amongst palliative care professionals - results from a national survey. BMC Palliat Care (2017) 0.75
Barriers and enablers for the development and implementation of allied health clinical practice guidelines in South African primary healthcare settings: a qualitative study. Health Res Policy Syst (2017) 0.75
Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA (1999) 40.60
Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof (2007) 2.92
Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLoS Med (2006) 2.67
Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci (2009) 2.48
Adapting clinical practice guidelines to local context and assessing barriers to their use. CMAJ (2009) 1.88
Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers. CMAJ (2010) 1.58
Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey. Scand J Prim Health Care (2008) 1.41
Clinical practice guidelines: barriers to durability after effective early implementation. Intern Med J (2005) 1.17
Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson's disease. A National Survey of German neurologists in private practice. J Neurol (2009) 1.06
Implementation of the Canadian Clinical Practice Guidelines for Nutrition Support: a multiple case study of barriers and enablers. Nutr Clin Pract (2007) 0.99
The relative effectiveness of practice change interventions in overcoming common barriers to change: a survey of 14 hospitals with experience implementing evidence-based guidelines. J Eval Clin Pract (2007) 0.96
Use of medical informatics to implement and develop clinical practice guidelines. West J Med (1998) 0.91
Quality improvement in the Estonian health system--assessment of progress using an international tool. Int J Qual Health Care (2006) 0.82
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
What essential medicines for children are on the shelf? Bull World Health Organ (2009) 3.84
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci (2013) 2.25
Medicalisation, limits to medicine, or never enough money to go around? BMJ (2002) 2.21
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev (2010) 2.11
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev (2014) 2.10
Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Med (2010) 1.74
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
Transfusion triggers: a systematic review of the literature. Transfus Med Rev (2002) 1.57
CONSORT 2010. Lancet (2010) 1.50
The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health (2010) 1.42
Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med (2013) 1.39
Saving womens lives: evidence-based recommendations for the prevention of postpartum haemorrhage. Bull World Health Organ (2007) 1.32
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol (2012) 1.30
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials (2009) 1.19
Introducing a complex health innovation--primary health care reforms in Estonia (multimethods evaluation). Health Policy (2006) 1.17
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev (2013) 1.12
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health (2012) 1.05
To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bull World Health Organ (2010) 1.02
Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr (2009) 0.98
Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med (2009) 0.93
What drives health-care spending priorities? An international survey of health-care professionals. PLoS Med (2007) 0.92
Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev (2013) 0.88
Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model. Health Policy (2006) 0.87
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr (2012) 0.87
Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One (2009) 0.86
The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines. J Clin Epidemiol (2012) 0.85
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res (2007) 0.83
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry. Arch Intern Med (2005) 0.83
Interactions between non-physician clinicians and industry: a systematic review. PLoS Med (2013) 0.83
Quality improvement in the Estonian health system--assessment of progress using an international tool. Int J Qual Health Care (2006) 0.82
Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc (2012) 0.82
Review of the quality of pediatric medications in developing countries. J Pharm Sci (2013) 0.81
Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines. Pediatr Infect Dis J (2004) 0.80
Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia. Health Policy (2007) 0.80
Decline in alcohol consumption in Estonia: combined effects of strengthened alcohol policy and economic downturn. Alcohol Alcohol (2011) 0.79
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropr Osteopat (2010) 0.79
An evaluation of the World Health Organization problem-based pharmacotherapy teaching courses (based on the "Guide to Good Prescribing"), 1994-2001. Eur J Clin Pharmacol (2005) 0.78
The Baltic states: building on 20 years of health reforms. BMJ (2012) 0.78
A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev (2014) 0.78
Children and tuberculosis medicines: bridging the research gap. Bull World Health Organ (2008) 0.78
WT1 expression does not disrupt myogenic differentiation in C2C12 murine myoblasts or in human rhabdomyosarcoma. Exp Cell Res (2003) 0.77
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77
Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom (2017) 0.76
Transparency in economic evaluations. Pharmacoeconomics (2005) 0.75
Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect (2014) 0.75
Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review. AIDS Patient Care STDS (2015) 0.75
Clarification of study and citation. Arch Intern Med (2007) 0.75
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect (2014) 0.75
Boosting access to essential medicines for children. Lancet (2006) 0.75
Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth (2020) 0.75
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract (2010) 0.75
The Cochrane Library Oversight Committee. Cochrane Database Syst Rev (2011) 0.75
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev (2016) 0.75